|
1
|
Arber DA, Orazi A, Hasserjian R, Thiele J,
Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M and Vardiman JW:
The 2016 revision to the World Health Organization classification
of myeloid neoplasms and acute leukemia. Blood. 127:2391–2405.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kralovics R, Passamonti F, Buser AS, Teo
SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M and Skoda RC: A
gain-of-function mutation of JAK2 in myeloproliferative disorders.
N Engl J Med. 352:1779–1790. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Levine RL, Wadleigh M, Cools J, Ebert BL,
Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, et
al: Activating mutation in the tyrosine kinase JAK2 in polycythemia
vera, essential thrombocythemia, and myeloid metaplasia with
myelofibrosis. Cancer Cell. 7:387–397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baxter EJ, Scott LM, Campbell PJ, East C,
Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N,
et al: Acquired mutation of the tyrosine kinase JAK2 in human
myeloproliferative disorders. Lancet. 365:1054–1061. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nowell PC: The minute chromosome (Phl) in
chronic granulocytic leukemia. Blut. 8:65–66. 1962. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rowley JD: Letter: A new consistent
chromosomal abnormality in chronic myelogenous leukaemia identified
by quinacrine fluorescence and Giemsa staining. Nature.
243:290–293. 1973. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tefferi A and Pardanani A:
Myeloproliferative, neoplasms: A contemporary review. JAMA Oncol.
1:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Levine RL: Mechanisms of mutations in
myeloproliferative neoplasms. Best Pract Res Clin Haematol.
22:489–494. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hinds DA, Barnholt KE, Mesa RA, Kiefer AK,
Do CB, Eriksson N, Mountain JL, Francke U, Tung JY, Nguyen HM, et
al: Germ line variants predispose to both JAK2 V617F clonal
hematopoiesis and myeloproliferative neoplasms. Blood.
128:1121–1128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qin YW, Yang YN, Li S and Wang C:
Coexistence of JAK2V617F mutation and BCR-ABL translocation in a
pregnant woman with essential thrombocythemia. Indian J Hematol
Blood Transfus. 30 Suppl 1:S331–S334. 2014. View Article : Google Scholar
|
|
11
|
Zhou A, Knoche EM, Engle EK, Fisher DA and
Oh ST: Concomitant JAK2 V617F-positive polycythemia vera and
BCR-ABL-positive chronic myelogenous leukemia treated with
ruxolitinib and dasatinib. Blood Cancer J. 5:e3512015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ursuleac I, Colita A, Adam T, Jardan C,
Ilea A and Coriu D: The concomitant occurrence of JAK2V617F
mutation and BCR/ABL transcript with phenotypic expression-an
overlapping myeloproliferative disorder or two distinct diseases?
-case report. J Med Life. 6:34–37. 2013.PubMed/NCBI
|
|
13
|
Pagnano KB, Delamain MT, Magnus MM,
Vassallo J, DE Souza CA, DE Almeida D and Lorand-Metze I:
Concomitant essential thrombocythemia with JAK2 V617F mutation in a
patient with chronic myeloid leukemia with major molecular response
with imatinib and long-term follow-up. Oncol Lett. 12:485–487.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van Dongen JJ, Macintyre EA, Gabert JA,
Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G,
Griesinger F, et al: Standardized RT-PCR analysis of fusion gene
transcripts from chromosome aberrations in acute leukemia for
detection of minimal residual disease. Report of the BIOMED-1
concerted action: Investigation of minimal residual disease in
acute leukemia. Leukemia. 13:1901–1928. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hummel JM, Kletecka MC, Sanks JK,
Chiselite MD, Roulston D, Smith LB, Czuchlewski DR,
Elenitoba-Johnson KS and Lim MS: Concomitant BCR-ABL1 translocation
and JAK2(V617F) mutation in three patients with myeloproliferative
neoplasms. Diagn Mol Pathol. 21:176–183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Michiels JJ, Ten Kate FWJ, De Raeve H and
Gadisseur A: Bone marrow features and natural history of
BCR/ABL-positive thrombocythemia and chronic myeloid leukemia
compared to BCR/ABL-negative thrombocythemia in essential
thrombocythemia and polycythemia vera. J Hematol Thromboembolic
Dis. 3:2015.
|
|
17
|
Pieri L, Spolverini A, Scappini B, Occhini
U, Birtolo S, Bosi A, Albano F, Fava C and Vannucchi AM:
Concomitant occurrence of BCR-ABL and JAK2V617F mutation. Blood.
118:3445–3446. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heller P, Kornblihtt LI, Cuello MT,
Larripa I, Najfeld V and Molinas FC: BCR-ABL transcripts may be
detected in essential thrombocythemia but lack clinical
significance. Blood. 98:19902001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bee PC, Gan GG, Nadarajan VS, Latiff NA
and Menaka N: A man with concomitant polycythaemia vera and chronic
myeloid leukemia: The dynamics of the two disorders. Int J Hematol.
91:136–139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kwong YL, Chiu EK, Liang RH, Chan V and
Chan TK: Essential thrombocythemia with BCR/ABL rearrangement.
Cancer Genet Cytogenet. 89:74–76. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
LeBrun DP, Pinkerton PH, Sheridan BL,
Chen-Lai J, Dubé ID and Poldre PA: Essential thrombocythemia with
the Philadelphia chromosome and BCR-ABL gene rearrangement. An
entity distinct from chronic myeloid leukemia and Philadelphia
chromosome-negative essential thrombocythemia. Cancer Genet
Cytogenet. 54:21–25. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Larsen TS, Hasselbalch HC, Pallisgaard N
and Kerndrup GB: A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10)
in polycythemia vera associated with a hyperproliferative phenotype
in transformation to postpolycythemic myelofibrosis. Cancer Genet
Cytogenet. 172:107–112. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Specchia G, Albano F, Anelli L, Storlazzi
CT, Zagaria A, Mancini M, Cuneo A, Pane F, Foà R, Manolelli F, et
al: Deletions on der(9) chromosome in adult Ph-positive acute
lymphoblastic leukemia occur with a frequency similar to that
observed in chronic myeloid leukemia. Leukemia. 17:528–531. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rumi E and Cazzola M: Diagnosis, risk
stratification, and response evaluation in classical
myeloproliferative neoplasms. Blood. 129:680–692. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tefferi A: Myeloproliferative neoplasms: A
decade of discoveries and treatment advances. Am J Hematol.
91:50–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
